Image showing a PICO summary for: Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial by Broderick et al. featured in the Transfusion Evidence Alert - March 2026
New from #Transfusion Evidence Library:
Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
by Broderick et al.
🔗 Link in the comments